Over 24 million men and women in the United States have COPD, yet there are individuals who are aware of all of their treatment options, such as the Lung Institute’s autologous stem cell therapy. Operating five clinics in Tampa, Fla., Nashville, Tenn., Scottsdale, Ariz., and Pittsburgh, Pa. and Dallas, Texas, the Lung Institute has treated over 3,000 patients with chronic lung diseases, and for people with COPD, 84.5 percent said that the quality of their life was better after treatment.
At the Third International Congress on Responsible Stem Cell Research in Italy, Jack Coleman, Jr., M.D. Senior Medical Director of the Lung Institute, spoke about how stem cell technologies are alleviating COPD patient’s (https://lunginstitute.com/lung-diseases/copd/) pain and suffering, despite dire prognoses.
Safe and effective, stem cell therapy at the Lung Institute uses a patient’s own stem cells to treat major pulmonary conditions by removing them from the patient’s blood or bone marrow and then reintroducing them into the body. Stem cells can take over the function of any tissue in the body, which is why stem cell therapy is regenerative medicine, as opposed to merely treating symptoms; in certain cases, it is possible for lungs to naturally regenerate. According to experts from the Baylor College of Medicine, with stem cell therapy, the Lung Institute is taking advantage of a naturally occurring process in the human body. When someone is hurt, stem cells, receive signals to begin the healing process, but in people with a chronic lung disease, the lung’s stem cells are depleted. Stem cell therapy is simply delivering new stem cells to the lungs.
Individuals interested in learning more about stem cell therapy to treat their chronic lung disease can contact the Lung Institute, where they will be matched with a patient care coordinator. The coordinator will answer all their questions and arrange a no-obligation consultation to see if stem cell therapy is a viable option. For more info, please visit lunginstitute.com.
admin March 3, 2017
Posted In: Stem Cell Therapy